Spectral Medical (TSX:EDT) Asset Impairment Charge : C$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Spectral Medical Asset Impairment Charge?

Spectral Medical's Asset Impairment Charge for the three months ended in Dec. 2024 was C$0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.00 Mil.

Spectral Medical Asset Impairment Charge Historical Data

The historical data trend for Spectral Medical's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spectral Medical Asset Impairment Charge Chart

Spectral Medical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Asset Impairment Charge

Get a 7-Day Free Trial

0.29

0.60

Spectral Medical Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Spectral Medical Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Spectral Medical Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Spectral Medical's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Spectral Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (TSX:EDT) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

EDTXF:USA SD4:Germany

Address

135 The West Mall, Unit 2, Finance, Toronto, ON, CAN, M9C 1C2

Website

https://www.spectraldx.com

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.

Executives

Paul M. Walker	Director
John Ernest Nosenzo	Director
Chris Seto	Senior Officer
William Charles Stevens	Director
Kevin Arnold Giese	Director
Gualtiero Piero Guido Maria Guadagni	Senior Officer
Debra-anne Foster	Deemed Insider - 6 Months before becoming Insider
Anthony Phillip Bihl	Director